Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Investigative and emerging treatments for Batten disease
Marta A. Tarczyluk
,
Jonathan D. Cooper
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Bursky Center for Human Immunology and Immunotherapy
Division of Genetics and Genomic Medicine
DBBS - Neurosciences
DBBS - Developmental, Regenerative and Stem Cell Biology
DBBS - Molecular Genetics and Genomics
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Investigative and emerging treatments for Batten disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Batten Disease
100%
Neuronal Ceroid Lipofuscinosis
100%
Emerging Treatments
100%
Experimental Therapeutics
50%
Neural Stem Cells
25%
Older Adults
25%
Clinical Trials
25%
Gene Therapy
25%
Transmembrane Protein
25%
Gene Products
25%
Disability
25%
Small Molecules
25%
Transmembrane
25%
Enzyme Replacement Therapy
25%
Effective Therapy
25%
Clinical Setting
25%
Expert Opinion
25%
Lysosomal Enzymes
25%
Combination Therapy
25%
Neurodegenerative
25%
Area Cover
25%
Not-knowing
25%
Gene Defects
25%
Storage Disorders
25%
Biochemistry, Genetics and Molecular Biology
Batten Disease
100%
Neuronal Ceroid Lipofuscinosis
100%
Enzyme
33%
Stem Cell
16%
Clinical Trial
16%
Gene Therapy
16%
Transmembrane Protein
16%
Gene Product
16%
Small Molecule
16%
Preclinical Study
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neuronal Ceroid Lipofuscinosis
100%
Lipofuscinosis
100%
Combination Therapy
25%
Clinical Trial
25%
Storage Disease
25%
Preclinical Study
25%
Lysosome Enzyme
25%
Neuroscience
Neuronal Ceroid Lipofuscinosis
100%
Ceroid
100%
Gene Product
25%
Lysosome Enzyme
25%
Transmembrane Protein
25%
Neural Stem Cell
25%